Literature DB >> 19626260

Knowledge and insight in relation to functional remission in patients with long-term psychotic disorders.

Malin Alenius1, Margareta Hammarlund-Udenaes, Per Hartvig, Leif Lindström.   

Abstract

BACKGROUND: Patients with psychotic symptoms often respond poorly to treatment. Outcomes can be affected by biological, physiological and psychological factors according to the vulnerability-stress model. The patient's coping strategies and beliefs have been correlated with outcomes.
OBJECTIVES: To investigate the knowledge and insight in relation to treatment response.
METHODS: A naturalistic study was performed using patient interviews and information gathered from patient drug charts. Apart from the rating scales used for classification of treatment response (CANSEPT method), the SPKS knowledge of illness and drugs rating scale was utilized.
RESULTS: In the group of patients in functional remission (FR; n = 38), 37% had insight into their illness as compared to 10% among those not in functional remission (non-FR; n = 78; P < 0.01). As much as 23% of the non-FR group had no strategy for responding to warning signs versus 8% in the FR group (P < 0.05).
CONCLUSIONS: Better treatment outcomes appear to be associated with better insight into illness, higher knowledge of warning signs and better coping strategies.

Entities:  

Mesh:

Year:  2009        PMID: 19626260     DOI: 10.1007/s00127-009-0096-3

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  38 in total

1.  Psychiatric inpatients' knowledge of medication at hospital discharge.

Authors:  C Clary; A Dever; E Schweizer
Journal:  Hosp Community Psychiatry       Date:  1992-02

Review 2.  Coping with hallucinated voices in schizophrenia: a review of self-initiated strategies and therapeutic interventions.

Authors:  John Farhall; Kenneth Mark Greenwood; Henry J Jackson
Journal:  Clin Psychol Rev       Date:  2007-01-16

3.  Further evidence for individual differences in placebo responding: an interactionist perspective.

Authors:  Andrew L Geers; Kristin Kosbab; Suzanne G Helfer; Paul E Weiland; Justin A Wellman
Journal:  J Psychosom Res       Date:  2007-05       Impact factor: 3.006

4.  The assessment of needs in psychiatric patients. Interrater reliability of the Swedish version of the Camberwell Assessment of Needs instrument and results from a cross-sectional study.

Authors:  L Hansson; T Björkman; B Svensson
Journal:  Acta Psychiatr Scand       Date:  1995-10       Impact factor: 6.392

5.  Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.

Authors:  Jennifer C Day; Richard P Bentall; Chris Roberts; Fiona Randall; Anne Rogers; Dinah Cattell; David Healy; Pam Rae; Cheryl Power
Journal:  Arch Gen Psychiatry       Date:  2005-07

6.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

7.  Insight as a predictor of the outcome of first-episode nonaffective psychosis in a prospective cohort study in England.

Authors:  Richard J Drake; Graham Dunn; Nick Tarrier; Richard P Bentall; Gillian Haddock; Shôn W Lewis
Journal:  J Clin Psychiatry       Date:  2007-01       Impact factor: 4.384

8.  The Camberwell Assessment of Need: the validity and reliability of an instrument to assess the needs of people with severe mental illness.

Authors:  M Phelan; M Slade; G Thornicroft; G Dunn; F Holloway; T Wykes; G Strathdee; L Loftus; P McCrone; P Hayward
Journal:  Br J Psychiatry       Date:  1995-11       Impact factor: 9.319

9.  Acceptable terminology and subgroups in schizophrenia: an exploratory study.

Authors:  David Kingdon; Anna Gibson; Yoshihiro Kinoshita; Douglas Turkington; Shanaya Rathod; Anthony Morrison
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-01-14       Impact factor: 4.328

10.  Insight, distress and coping styles in schizophrenia.

Authors:  Michael Cooke; Emmanuelle Peters; Dominic Fannon; Anantha P P Anilkumar; Ingrid Aasen; Elizabeth Kuipers; Veena Kumari
Journal:  Schizophr Res       Date:  2007-06-11       Impact factor: 4.939

View more
  3 in total

1.  Neurocognition, insight and medication nonadherence in schizophrenia: a structural equation modeling approach.

Authors:  Laurent Boyer; Michel Cermolacce; Daniel Dassa; Jessica Fernandez; Mohamed Boucekine; Raphaelle Richieri; Florence Vaillant; Remy Dumas; Pascal Auquier; Christophe Lancon
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

2.  Predicting functional remission in patients with schizophrenia: a cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome.

Authors:  Marcelo Valencia; Ana Fresán; Yoram Barak; Francisco Juárez; Raul Escamilla; Ricardo Saracco
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-10       Impact factor: 2.570

3.  The association between cannabis use and outcome in pharmacological treatment for opioid use disorder.

Authors:  Tea Rosic; Raveena Kapoor; Balpreet Panesar; Leen Naji; Darren B Chai; Nitika Sanger; David C Marsh; Andrew Worster; Lehana Thabane; Zainab Samaan
Journal:  Harm Reduct J       Date:  2021-02-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.